Citius Pharmaceuticals Inc
NASDAQ:CTXR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
US |
|
ConvaTec Group PLC
LSE:CTEC
|
UK |
|
S
|
SPAR Group Ltd
JSE:SPP
|
ZA |
Multiples-Based Value
The Multiples-Based Value for
Citius Pharmaceuticals Inc (CTXR) under the Base Case is 3.6828 USD.
Compared with the current market price of 0.5726 USD, the stock appears
Undervalued by 84% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.